Castellanos v. Pfizer, Inc.

555 F. Supp. 2d 1343, 2008 U.S. Dist. LEXIS 89233, 2008 WL 2127987
CourtDistrict Court, S.D. Florida
DecidedMay 20, 2008
DocketCase 07-60646-CIV
StatusPublished
Cited by4 cases

This text of 555 F. Supp. 2d 1343 (Castellanos v. Pfizer, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Castellanos v. Pfizer, Inc., 555 F. Supp. 2d 1343, 2008 U.S. Dist. LEXIS 89233, 2008 WL 2127987 (S.D. Fla. 2008).

Opinion

ORDER

WILLIAM J. ZLOCH, District Judge.

THIS MATTER is before the Court upon Defendants United States of America and Secretary of State Condoleeza Rice’s Motion To Dismiss Second Amended Complaint (DE 62). The Court has carefully reviewed said Motion and the entire court file and is otherwise fully advised in the premises.

I. Introduction

The above-styled cause involves allegations by Plaintiffs that agents of Pfizer, Inc. (hereinafter “Pfizer”) conspired with employees of the United States Department of State (hereinafter “State Department”) to advance the business objectives of Pfizer by using threats, bribes, and other adverse actions that harmed Plaintiffs. Specifically, Plaintiffs allege that Defendants are liable for injuries resulting from being defamed and having their United States visas revoked. The United States argues that none of its employees are personally liable in tort because they were acting within the scope of their employment, and thus the United States should be substituted as a Party Defendant in their place for Counts I and II. The Government further argues that the United States is immune from Counts I and II, the Court lacks jurisdiction over Count V because visa revocations are non-reviewable, and Count VI should be dismissed for failure to state a claim upon which relief may be granted.

II. Background

The basis for this action arises in the context of two drug companies attempting to obtain the right to distribute sildenafil in Ecuador: Acromax, an Ecuadorean pharmaceutical corporation, and Pfizer. 1 Plaintiff Luis Alberto Vera Castellanos was an Ecuadorean patent court judge at the time relevant to this case. Plaintiffs Xavier Neira, Jorge Neira, and Eduardo Garcia are members of a legal and economic services firm Neira and Associates (hereinafter “N & A”). N & A has represented Acromax, a competitor of Pfizer, regarding a patent on the drug sildenafil, sold under the name ‘Viagra” in the United States. Plaintiffs filed their Second Amended Complaint (DE 59) (hereinafter “Complaint”) against Pfizer, the State Department, Condoleeza Rice, as Secretary of State, and James Sullivan, Elizabeth Jordan, and Aaron Sherinian, in their personal capacities. At all times relevant to the above-styled cause, Defendants Sullivan, Jordan, and Sherinian worked in various roles for the State Department at the U.S. Embassy in Quito, Equador.

Several years prior to initiating this action, Acromax began the process necessary to obtain a patent to distribute sildenafil. DE 59, ¶ 16 (hereinafter “Complaint”). Initially, Acromax filed an administrative action before the Ecuadorian Institute of Intellectual Property (hereinafter “IEPI”), and when that action stalled, it filed a suit in an Ecuadorean court. Id. ¶ 17. On March 14, 2006, Dr. Jose Alvear Icaza, a representative of Pfizer, together with Sullivan, met with Jorge Neira and Eduardo Garcia and threatened them with “grave repercussions if plaintiff Garcia continued to represent Acromax.” Id. ¶ 21. Plaintiffs brought this incident to the attention *1346 of the United States Ambassador in Ecuador, who responded that Sullivan was acting to preserve the interests of a U.S. corporation. Id.

Sullivan approached Castellanos and informed him that certain judicial decisions made by Castellanos would be “considered a direct attack against the American Government and its corporations.” Id. ¶ 23. Additionally, Sullivan offered a scholarship and educational assistance in the United States for Castellanos’s daughter in exchange for a favorable ruling. Id.

Plaintiffs then received notification from Defendant Jordan that their visas were revoked pursuant to section 212 of the Immigration and Nationality Act, thereby denying them the ability to freely travel to the United States to visit family. 8 U.S.C. § 1201(i) (2006); Complaint, ¶¶28, 33. Plaintiffs were later informed that the revocations were pursuant to Presidential Proclamation 7750. 69 Fed.Reg. 2287 (Jan. 12, 2004); Complaint, ¶ 28. Thereafter, Defendant Sherinian issued press releases accusing Plaintiffs of public corruption and stated the visa revocation was necessary to protect the United States from crime and terrorism. Id. ¶ 29.

The Complaint alleges the following causes of action against all named defendants: 1) Defamation and Conspiracy to Defame; 2) Tortious Interference with Business Relations; 3) Violation of the Foreign Corrupt Practices Act; 4) Violation of the Racketeer Influenced and Corrupt Organization Act; 5) Injunctive Relief for Wrongful Revocation of Visas; and 6) Facial and As-Applied Challenges to the Constitutionality of Presidential Proclamation 7750.

Plaintiffs subsequently dropped Counts I through IV against the State Department and Secretary Rice. DE 64, ¶ 7. Plaintiffs further clarified that Counts I through IV apply only against Pfizer and Sullivan, Jordan, and Sherinian, in their personal capacities. Id. In the course of litigation, United States Attorney for the Southern District of Florida R. Alexander Acosta, Esquire, filed a Certification (DE 61) pursuant to 28 U.S.C. § 2679(d) certifying that Defendants James F. Sullivan, Elizabeth Jordan, and Aaron Sherinian (hereinafter “federal employees”) were employees of the U.S. Department of State, and were acting within the scope of their employment at the time of the alleged incidents that gave rise to this action.

III. Standard of Review

The instant Motion mounts a facial attack on the subject matter jurisdiction of the Court under Federal Rule of Civil Procedure 12(b)(1). On a facial attack, courts review the complaint to determine if “plaintiff has sufficiently alleged a basis of subject matter jurisdiction, and the allegations in [the] complaint are taken as true for the purposes of the motion.” Lawrence v. Dunbar, 919 F.2d 1525, 1529 (11th Cir.1990). Thus, if sovereign immunity shields a defendant from suit, Rule 12(b)(1) is the proper vehicle for dismissal. See Bennett v. United States, 102 F.3d 486, 488 n. 1 (11th Cir.1996).

IV. Analysis

The Court will begin by addressing whether the Certification is sufficient to substitute the United States as a Party Defendant in place of the federal employees for Counts I and II. If it is sufficient, the United States must be substituted on those counts, and the analysis proceeds to determine whether the United States is immune from Counts I and II. The Certification is not conclusive; rather, it constitutes prima facie

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
555 F. Supp. 2d 1343, 2008 U.S. Dist. LEXIS 89233, 2008 WL 2127987, Counsel Stack Legal Research, https://law.counselstack.com/opinion/castellanos-v-pfizer-inc-flsd-2008.